Home LiteratureArticle Details
PMID: 16008550 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels.

The FEBS journal ·Vol. 272 ·No. 14 ·2005-07-00 ·Pages 3491-504

Dumaz N, Marais R

Abstract

One of the hallmarks of cAMP is its ability to inhibit proliferation in many cell types, but stimulate proliferation in others. Clearly cAMP has cell type specific effects and the outcome on proliferation is largely attributed to crosstalk from cAMP to the RAS/RAF/mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK pathway. We review the crosstalk between these two ancient and conserved pathways, describing the molecular mechanisms underlying the interactions between these pathways and discussing their possible biological importance.

MeSH Terms
Animals Cell Proliferation Cyclic AMP/metabolism Humans MAP Kinase Signaling System Mitogen-Activated Protein Kinase Kinases/metabolism raf Kinases/metabolism ras Proteins/metabolism
Chemicals
Cyclic AMP raf Kinases Mitogen-Activated Protein Kinase Kinases ras Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dumaz Nicolas
Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London, UK.
Marais Richard
Article Info
Journal
The FEBS journal
Abbr.
FEBS J
ISSN
1742-464X
Published
2005-07-00
Pages
3491-504
Language
English
Region
England
NLM ID
101229646
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com